This dual mechanism makes neuroblastoma an attractive target population for PLK4i like RP-1664 and adds to a growing list of factors predictive of PLK4i sensitivity, including high TRIM37 levels9,10 or b-Catenin hyperactivation56, the latter of which is seldomly observed in high-risk neuroblastoma. Here, TRIM37 is linked to neuroblastoma.